Seven Fleet Capital Management LP Acquires New Position in Spyre Therapeutics, Inc. $SYRE
Seven Fleet Capital Management LP bought a new position in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) in the first quarter, Holdings Channel reports. The institutional investor bought 19,690 shares of the company’s stock, valued at approximately $993,000. Several other hedge funds and other institutional investors have also bought and sold shares of SYRE. Summit […]
2 Aug 11:06 · The Markets Daily